Invention Grant
- Patent Title: Reverse genetics using non-endogenous pol I promoters
- Patent Title (中): 反向遗传学使用非内源性pol I启动子
-
Application No.: US13320902Application Date: 2010-05-21
-
Publication No.: US09072702B2Publication Date: 2015-07-07
- Inventor: Philip Dormitzer , Michael Franti , Peter Mason , Pirada Suphaphiphat , Bjoern Keiner , Stefania Crotta
- Applicant: Philip Dormitzer , Michael Franti , Peter Mason , Pirada Suphaphiphat , Bjoern Keiner , Stefania Crotta
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Morrison & Foerster LLP
- International Application: PCT/IB2010/001332 WO 20100521
- International Announcement: WO2010/133964 WO 20101125
- Main IPC: C12N7/02
- IPC: C12N7/02 ; C12N7/01 ; C12N5/10 ; C12N15/85 ; A61K39/12 ; A61K39/145
Abstract:
Expression of a transgene is driven in a host cell using a pol I promoter which is not endogenous to an organism from the same taxonomic order from which the host cell is derived.
Public/Granted literature
- US20120189656A1 REVERSE GENETICS USING NON-ENDOGENOUS POL I PROMOTERS Public/Granted day:2012-07-26
Information query
